PressSeptember 2, 2020 Revive Therapeutics Enters into Clinical Trial Agreement to Evaluate Psilocybin for the Treatment of Methamphetamine Use Disorder
PressSeptember 1, 2020 Better Plant Sciences Adds eCommerce Sales of 200 Plant-Based Products Through Agreement with JUSU
PressAugust 31, 2020 Mindset Pharma Announces Promising Test Results of its Novel and Proprietary Psilocybin-Inspired Compounds
PressAugust 28, 2020 Champignon to Begin Offering Esketamine Treatment for Adults With Major Depressive Disorder at the Canadian Rapid Treatment Centre of Excellence
PressAugust 28, 2020 New Wave Holdings Announces Definitive Agreement to Acquire Additional 25% Interest in Anahit Therapeutics
PressAugust 27, 2020 Better Plant Sciences Announces Website Launch and Strategic Plan to Grow Direct-to-Consumer Sales
PressAugust 26, 2020 Revive Therapeutics Announces Submission of IRB Approval for Phase 3 Clinical Trial Protocol for Bucillamine in COVID-19
PressAugust 25, 2020 PSYC Continuing Its Path of Becoming Content Leader in The Psychedelic Space Through Key Interviews
PressAugust 24, 2020 Ehave Announces Plans to Accelerate the Monetization of its Proprietary Digital Health Platform
PressAugust 24, 2020 Field Trip Psychedelics Inc. Announces Closing of $11.0 million Financing, Entry into Amalgamation Agreement with Newton Energy Corporation
PressAugust 21, 2020 ATAI and IntelGenx enter into Feasibility Agreement to develop pharmaceutical-grade polymeric film technologies for delivery of psychedelic medicines
PressAugust 21, 2020 Psychedelic Research Fundraising Campaign Attracts $30 Million in Donations in 6 Months, Prepares MDMA-Assisted Psychotherapy for FDA Approval
PressAugust 19, 2020 PSYC Establishes New Partnership with Industry Leader, Microdose Psychedelic Insights
PressAugust 18, 2020 Mydecine™ Launches World’s First Natural-Sourced cGMP Psilocybin for Global Research, Sales, and Distribution Enterprise
PressAugust 13, 2020 Mydecine Innovations Group Featured in Forbes for the First-Of-Its-Kind Clinicals Using Psilocybin Therapy For PTSD